ID

14481

Description

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00895895

Lien

https://clinicaltrials.gov/show/NCT00895895

Mots-clés

  1. 17/04/2016 17/04/2016 -
Téléchargé le

17 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Alzheimer Disease NCT00895895

Eligibility Alzheimer Disease NCT00895895

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
Description

alzheimers disease; NINCDS-ADRDA Criteria

Type de données

boolean

Alias
UMLS CUI [1]
C0002395
UMLS CUI [2]
C2828081
mini-mental state examination (mmse) score of 12 to 24 at screening
Description

mini-mental state examination

Type de données

boolean

Alias
UMLS CUI [1]
C0451306
rosen modified hachinski ischemic score < or equal to 4 at screening.
Description

Modified Hachinski Ischemic Scale

Type de données

boolean

Alias
UMLS CUI [1]
C3826978
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
Description

neurologic disease

Type de données

boolean

Alias
UMLS CUI [1]
C0027765
current major depressive disorder or other current major psychiatric disorder.
Description

depressive disorder; psychiatric disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0011581
UMLS CUI [2]
C0004936
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
Description

stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque

Type de données

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007282
UMLS CUI [3]
C0149810
UMLS CUI [4]
C0332461
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
Description

memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors

Type de données

boolean

Alias
UMLS CUI [1]
C0025242
UMLS CUI [2]
C0330206
UMLS CUI [3]
C0063033
UMLS CUI [4]
C0008425

Similar models

Eligibility Alzheimer Disease NCT00895895

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
alzheimers disease; NINCDS-ADRDA Criteria
Item
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
boolean
C0002395 (UMLS CUI [1])
C2828081 (UMLS CUI [2])
mini-mental state examination
Item
mini-mental state examination (mmse) score of 12 to 24 at screening
boolean
C0451306 (UMLS CUI [1])
Modified Hachinski Ischemic Scale
Item
rosen modified hachinski ischemic score < or equal to 4 at screening.
boolean
C3826978 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
neurologic disease
Item
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
boolean
C0027765 (UMLS CUI [1])
depressive disorder; psychiatric disorder
Item
current major depressive disorder or other current major psychiatric disorder.
boolean
C0011581 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque
Item
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
boolean
C0038454 (UMLS CUI [1])
C0007282 (UMLS CUI [2])
C0149810 (UMLS CUI [3])
C0332461 (UMLS CUI [4])
memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors
Item
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
boolean
C0025242 (UMLS CUI [1])
C0330206 (UMLS CUI [2])
C0063033 (UMLS CUI [3])
C0008425 (UMLS CUI [4])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial